CHAUDHURI BHASKAR 4

What Happened

• Bhaskar Chaudhuri, a non-employee director of Tarsus Pharmaceuticals (TARS), received two awards on June 25, 2026: an option covering 3,837 shares (derivative) and 2,417 restricted stock units (RSUs). Both awards show $0.00 paid (they were grants/awards, not purchases). These are compensation grants tied to his service as a director rather than open-market buying or selling.

Key Details

• Transaction date: 2026-06-25; Filing date (Form 4): 2026-06-29 (filed within the standard two business days).
• Prices: reported at $0.00 (awards/grants).
• Shares/units awarded: 3,837 (option) and 2,417 RSUs.
• Shares owned after transaction: not specified in the provided filing details.
• Footnotes: F1—the option is an annual non-employee director grant that vests in full one year after grant, subject to continuous service. F2—each RSU equals a contingent right to one share. F3—RSUs vest in full one year after grant, subject to continuous service.

Context

• The option is a derivative award (no immediate share issuance); the RSUs are rights to receive shares upon vesting. Both awards vest in one year if Chaudhuri continues as a director. These types of annual director grants are routine compensation and do not indicate an immediate purchase or sale of shares.